Andrea Kruse, Director, Community Oncology Research Program at Dana-Farber Cancer Institute, discusses the different models it uses in community clinics to bring clinical trials as a care option to more patients, managing physician time and reducing physician burden, while pursuing trials that are a fit for the community setting.
Lead Editorial
